Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-04-24 @ 3:10 AM
Study NCT ID:
NCT03295227
Status:
RECRUITING
Last Update Posted:
2025-08-01
First Post:
2017-09-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Sponsor:
Organization: